🩺 Phase 9 · v3.5 · Specialty Deepening · 7 Jan - 21 Apr 2030 · 15 Weeks · 5 Sprints
← Hub ← Phase 8 Phase 10 → 🩺 Phase 9 v3.5 Specialty

Phase 9 · v3.5 · Specialty Deepening

Five new specialty modules — Mental Health (M17) · Dermatology (M18) · Endocrinology (M19) · Orthopaedics (M20) · Oncology (M21). Each with disease-specific pathways, validated screening instruments, specialist HITL workflows. By Q2-end 2030: 500+ tenants across ASEAN, 21 modules, deepest specialty surface area of any ASEAN clinic platform.

1. 🎯 Phase Summary

PhasePhase 9 · v3.5 · Specialty Deepening
Duration7 Jan - 21 Apr 2030 (15 weeks · 5 sprints × 3 weeks)
Goal5 specialty modules (M17 Mental Health · M18 Dermatology · M19 Endocrinology · M20 Orthopaedics · M21 Oncology) · validated instruments · specialty HITL · scale 300 → 500+ tenants

2. 🎨 Themes

  • Validated screening instruments — PHQ-9 + GAD-7 (M17) · dermatology image AI with biopsy referral safety (M18) · DM-1/thyroid/adrenal panels (M19) · fracture AI + MSK pathway (M20) · staging tools + chemo/palliative protocols (M21).
  • Specialist HITL — Every specialty module has specialist-tier human-in-the-loop. GP escalates to psychiatrist · dermatologist · endocrinologist · orthopaedic surgeon · oncologist. Specialist on-call rota with SLA.
  • Risk-graded surface area — Suicide risk (M17) · skin cancer (M18) · DKA (M19) · open fracture (M20) · febrile neutropenia (M21) — each gets dedicated red-flag workflows with mandatory specialist sign-off.
  • Cross-module care plans — Diabetic with depression (M19+M17) · oncology with chronic pain (M21+M20) · post-treatment skin reactions (M21+M18) — composite care plans across specialties.
  • Specialist marketplace — Specialists join MediEco as panel — GP clinics tap regional specialist pool. Cross-border specialist consult enabled via M8.

3. 🏃 Sprint Catalog

5. 📊 Success Metrics

500+
Tenants live across ASEAN
21
Total modules (M1-M21)
5
New specialty modules
150+
Specialists on panel
15+
Validated clinical instruments
30+
Cross-module care pathways

6. 🚪 Phase Exit Criteria

  • 5 specialty modules production-certified by respective specialty colleges
  • External clinical safety audit clean across all 5 modules
  • Specialist panel ≥ 30 per specialty across 4 countries
  • Composite cross-specialty care plans tested with ≥ 100 patients
  • PHQ-9 · GAD-7 · TNM · DKA red-flag instruments validated by Doc Zam advisory board
  • 500+ tenants confirmed live across ASEAN
  • v3.5 phase closeout demo · public clinical attestation

7. 🔮 Beyond This Phase

v4.0 (Phase 10) pivots from clinical depth to whole-stack reach. Consumer-direct mobile · employer wellness programs · clinical research recruitment · pharma trial network · ASEAN healthcare AI standard. MediEco moves from clinic platform to consumer + enterprise + research three-sided market.